Pharma-Bio Serv Inc. (OTCMKTS:PBSV – Get Free Report) saw a significant increase in short interest in October. As of October 15th, there was short interest totaling 2,008 shares, an increase of 109.6% from the September 30th total of 958 shares. Approximately 0.0% of the shares of the stock are sold short. Based on an average daily volume of 13,020 shares, the days-to-cover ratio is currently 0.2 days.
Pharma-Bio Serv Price Performance
Shares of OTCMKTS:PBSV traded up $0.12 during trading hours on Friday, hitting $0.52. 150 shares of the company’s stock traded hands, compared to its average volume of 4,516. The business has a fifty day moving average price of $0.48 and a 200-day moving average price of $0.51. The firm has a market capitalization of $11.91 million, a P/E ratio of 52.05 and a beta of 0.69. Pharma-Bio Serv has a 1 year low of $0.32 and a 1 year high of $0.65.
About Pharma-Bio Serv
Pharma-Bio Serv, Inc is a professional services and consulting company that supports pharmaceutical, biotechnology, medical device, and related life sciences organizations. Its work is focused on helping clients develop, implement, and maintain the technical, quality, and regulatory systems required to manufacture and commercialize healthcare products.
The company provides services that may include validation, regulatory compliance, quality assurance, engineering, technical consulting, project management, and support for manufacturing and facility-related initiatives.
Featured Articles
- Five stocks we like better than Pharma-Bio Serv
- Eli Lilly’s First Full Medicare Quarter: Is Volume Still Outrunning Price Cuts?
- Oracle’s AI Spending Peak Is in Sight—Can the Stock Recover?
- LyondellBasell’s Dividend Looks Safer, But a New Risk Could Change That
- L3Harris Stock Took a Beating—Is a 20% Rebound Next?
Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with MarketBeat.com's FREE daily email newsletter.
